Haben Sie sich noch nicht registriert? Hier kostenlos Ihr Konto eröffnen.
Passwort vergessen? Wir werden Ihnen einen Zurücksetzen Link senden
25 März 2019
Glycotope Expands Phase Ib Trial of Combination of Proprietary Anti-Tumor Antibodies to Include Marketed Anti-Tumor Antibodies (news with additional features)
30 Juli 2018
Glycotope GmbH: Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate (news with additional features)
18 Juli 2018
DCprime and Glycotope announce licensing agreement and collaboration (news with additional features)
22 Dezember 2017
Glycotope Initiates Phase Ib Trial of Combination of Proprietary Anti-Tumor Antibodies (news with additional features)
21 September 2017
Glycotope lizensiert GlycoExpress Zelllinie an Airway Therapeutics
29 April 2016
Glycotope GmbH: Glycotope ernennt Dr. Alfredo Zurlo zum Chief Medical Officer